-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

503.P1.36 503. Clonal Hematopoiesis, Aging and Inflammation: Poster I Clinically Relevant Abstract

Symposia: Clonal Hematopoiesis, Aging and Inflammation Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 10, 2022: 5:30 PM-7:30 PM
Hall D (Ernest N. Morial Convention Center)
Recent advances in our understanding of clonal hematopoiesis and the aging hematopoietic system.

Kira A Young, PhD1, Jayna J Mistry, PhD1*, James Chavez, BS2*, Eric M Pietras, PhD2,3 and Jennifer J J Trowbridge, PhD1

1The Jackson Laboratory, Bar Harbor, ME
2Division of Hematology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO
3Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, CO

Ashwin Kishtagari, MBBS1, MA Wasay Khan*, MBBS2*, Yajing Li*, MS2*, Cosmin Bejan, PhD3*, Naimisha Marneni, MBBS2*, Alexander J. Silver, BA4, Kelly von Beck, BS5, Travis Spaulding, MD6, Shannon Stockton, MD4*, Christina A. Snider, MD7, Kelly Pugh, MD6, Andrew Sochacki, MD8, Dixon Dorand, MD, PhD6*, Taralynn Mack9*, Caitlyn Vlasschaert, MD10*, Brent Ferrell, MD6, Yaomin Xu, PhD11*, Michael R. Savona, MD12 and Alexander G. Bick, MD, PhD13*

1Division of Hematology & Oncology, Vanderbilt Ingram Cancer Center, Franklin, TN
2Vanderbilt University Medical Center, Nashville
3Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN
4Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN
5Vanderbilt University, Nashville, TN
6Department of Medicine, Vanderbilt University Medical Center, Nashville, TN
7Department of Internal Medicine, Vanderbilt University Medical Center, Nashville, TN
8Department of Medicine and Program in Cancer Biology, Vanderbilt University School of Medicine, Nashville, TN
9Vanderbilt University School of Medicine, Nashville
10Department of Medicine, Queen's University, Kingston, ON, CAN
11Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN
12Vanderbilt University School of Medicine, Nashville, TN
13Division of Genetic Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN

Christopher M Arends1*, Thomas G Liman, MD2,3,4,5,6*, Paulina Strzelecka, PhD1*, Anna Kufner, MD PhD6*, Shufan Huo, MD6*, Catarina M Stein, MSc1*, Sophie Piper, PhD6,7,8*, Marlon Tilgner1*, Pia S Sperber, MD6*, Savvina Dimitriou1*, Peter Heuschmann, MD9*, Raphael Hablesreiter, MSc1*, Christoph Harms, MD2,4,6*, Lars Bullinger, MD1,10, Matthias Endres, MD2,3,4,6* and Frederik Damm, MD1,10*

1Department of Hematology, Oncology, and Cancer Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany
2Center for Stroke Research Berlin (CSB) with Department of Experimental Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany
3German Center for Neurodegenerative Diseases, Berlin, Germany
4German Center for Cardiovascular Research, Berlin, Germany
5Department of Neurology, Carl von Ossietzky-University, Evangelical Hospital Oldenburg, Oldenburg, Germany
6Department of Neurology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany
7Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Charité - Universitätsmedizin Berlin, Berlin, Germany
8NeuroCure Clinical Research Center, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
9University of Wuerzburg, Wuerzburg, Germany
10German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany

Rohan Kodgule, MD, MBBS1*, Joshua Robinson2*, Sridhar Nonavinkere Srivatsan, MS3*, Cara Lunn Shirai, PhD2, Feiyu Du3*, Tianjiao Wang2, Ajay Khanna3*, Catrina Fronick, BS4*, Robert Fulton, MS4*, David H Spencer, MD, PhD3, Matthew J Walter, MD3 and Eric Duncavage, M.D.2*

1Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO
2Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO
3Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO
4McDonnell Genome Institute, Washington University School of Medicine, Saint Louis, MO

Michael D Ashby, MD1*, Natasha S Anstee, PhD1,2*, Tongted Das, PhD1*, Ing S Tiong, FRACP, FRCPA, MPhil1,3, Sun Loo, MBBS, FRACP, FRCPA1, Andrew Spencer1 and Andrew H. Wei, MBBS, FRACP, FRCPA, PhD1,2,4

1The Alfred Hospital and Monash University, Melbourne, VIC, Australia
2The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia
3Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
4Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia

Anne Sonnenschein, Ph.D.1*, Elle Moore1*, Christine Lo, Ph.D.1*, Peter Kang, M.D.1*, Timothy J Taxter, M.D.1*, Brett Mahon, M.D.2* and Duane C Hassane, Ph.D.3

1Tempus Labs, Inc., Chicago, IL
2Tempus Labs, Inc, Chicago, IL
3Tempus Labs, Inc., New York, NY

Masahiro Marshall Nakagawa, MD, PhD1, Ryosaku Inagaki, MSc1,2*, Yutaka Kuroda, MD, PhD3*, Yasuhito Nannya, M.D., Ph.D.1, Lanying Zhao, MD, PhD1*, Yotaro Ochi, MD, PhD1*, June Takeda, MD1*, Qi Xingxing, PhD1*, Akinori Yoda, PhD4*, Ayana Kon, MD, PhD1*, Nobuyuki Kakiuchi, MD, PhD1*, Hideki Makishima, MD, PhD1, Shuichi Matsuda, MD, PhD3* and Seishi Ogawa, MD, PhD1,5,6

1Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
2DSP Cancer Institute, Sumitomo Dainippon Pharma Co., Ltd., Osaka, Japan
3Department of Orthopaedic Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan
4Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto City, Japan
5Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto, Japan
6Center for Hematology and Regenerative Medicine, Department of Medicine (MedH), Karolinska Institutet, Huddinge, Sweden

Matthew T. Jenkins, BS1,2*, Timothy J Scott, BS3*, Lindsey N Guerin, BS4*, Alana M Franceski, BS5*, Yunli E Chu, BS6*, Pawan Bhat, BS7, Chad R. Potts, BS8*, Robert S. Welner, PhD5*, Emily Hodges, PhD9,10* and Brent Ferrell, MD11

1Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN
2Department of Pharmacology, Vanderbilt University, Nashville, TN
3Vanderbilt Genetics Institute, Vanderbilt University School of Medicine, Nashville, TN
4Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN
5Division of Hematology/Oncology, University of Alabama At Birmingham, Birmingham, AL
6Program in Cancer Biology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN
7Program in Cancer Biology, School of Medicine, Vanderbilt University, Nashville, TN
8Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN
9Department of Biochemistry, Vanderbilt University Medical Center, Nashville, TN
10Vanderbilt Genetics Institute, Vanderbilt University Medical Center, Nashville, TN
11Department of Medicine, Vanderbilt University Medical Center, Nashville, TN

Alexander J. Silver, BA1, Donovan J. Brown, BS1*, Maria P. Arrate, BS1*, Yu Wang, PhD2*, Melissa A. Fischer, MSc, PhD1, Pawan Bhat, BS1, J. Brett Heimlich, MD, PhD1*, Alexander G. Bick, MD, PhD3*, P. Brent Ferrell, MD4,5*, Yaomin Xu, PhD2* and Michael R. Savona, MD4,5

1Department of Medicine, Vanderbilt University Medical Center, Nashville, TN
2Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN
3Division of Genetic Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN
4Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN
5Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN

Zhuoer Xie, MD, MS1, Alexandra Smith, MS2*, Rami S. Komrokji3, Najla Al Ali, MS4, Anand Ashwin Patel, MD5, Caner Saygin, MD6, Amer M. Zeidan, MD7, Jan Philipp Bewersdorf, MD8, Ashwin Kishtagari, MBBS9, Joshua F. Zeidner, MD10, Catherine C. Coombs, MD11, Yazan F. Madanat, MD12, James M. Foran, MD13, Talha Badar, MD14, Pinkal Desai, MD, MPH15, Charlton Tsai, MD15*, Elizabeth A. Griffiths, MD16, Monzr M. Al Malki, MD17, Idoroenyi Amanam, MD17, Catherine Lai, MD, MPH18, Joachim Deeg, MD19*, Lionel Ades20, Cecilia Arana Yi, MD, MSHS21, Afaf Osman, MD22, Shira Dinner, MD23, Yasmin Abaza, MD23, Namrata Chandhok, MD24*, Deborah Soong, MD24*, Justin Taylor, MD25, Andrew M. Brunner, MD26, Hetty E. Carraway, MD, MBA27, Abhay Singh, MD, MPH28, Susan M. Geyer, PhD29*, Eric Padron, MD30, Mrinal M. M. Patnaik, MD, MBBS31, Michael R. Savona, MD32 and Aref Al-Kali, MD31

1Division of Hematology, Mayo Clinic, Lutz, FL
2Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
3H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
4Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
5Department of Medicine, Section of Hematology/Oncology, University of Chicago Medical Center, Chicago, IL
6Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL
7Department of Internal Medicine, Yale School of Medicine and Yale Cancer Center, New Haven, CT
8Department of Medicine; Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY
9Department of Internal Medicine, Division of Hematology, Vanderbilt University School of Medicine; Ingram Cancer Center, Nashville, TN
10UNC - Lineberger Comprehensive Cancer Center, Chapel Hill, NC
11Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC
12Division of Hematology/Oncology, Department of Internal Medicine, University of Texas Southwestern, Dallas, TX
13Division of Hematology/Oncology and Blood and Marrow Transplanation and Cellular Therapy, Mayo Clinic, Jacksonville, FL
14Division of Hematology and Oncology, Mayo Clinic Florida, Jacksonville, FL
15Division of Hematology and Oncology, Weill Cornell Medicine and The New York-Presbyterian Hospital, New York, NY
16Roswell Park Comprehensive Cancer Center, Buffalo, NY
17Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
18University of Pennsylvania Perelman Center for Advanced Medicine, Philadelphia, PA
19Fred Hutchinson Cancer Center, Seattle, WA
20Department of Hematology, Université de Paris, Saint-Louis Hospital, Paris, France
21Mayo Clinic, Phoenix, AZ
22Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
23Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL
24Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
25University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL
26Mass General Cancer Center, Massachusetts General Hospital, Boston, MA
27Department of Hematology and Medical Oncology, Taussig Cancer institute, Leukemia Program, Cleveland Clinic, Cleveland, OH
28Department of Hematology and Medical Oncology, Taussig Cancer Institute, Leukemia Program, Cleveland Clinic Foundation, Cleveland, OH
29Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, MN
30Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL
31Division of Hematology, Mayo Clinic, Rochester, MN
32Vanderbilt University School of Medicine, Nashville, TN

Pawan Bhat, BS1, J. Brett Heimlich, MD, PhD2*, Alyssa Parker, BS3*, Matthew T. Jenkins, BS4*, Chad R. Potts, BS2*, Jessica Ulloa, BS2*, Alexander J. Silver, BA5, Donovan J. Brown, BS2*, Peter van Galen, PhD6, Michael R. Savona, MD7, Alexander G. Bick, MD, PhD3* and Brent Ferrell, MD2

1Program in Cancer Biology, School of Medicine, Vanderbilt University, Nashville, TN
2Department of Medicine, Vanderbilt University Medical Center, Nashville, TN
3Division of Genetic Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN
4Department of Pharmacology, Vanderbilt University, Nashville, TN
5Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN
6Massachusetts General Hospital, Boston, MA
7Vanderbilt-Ingram Cancer Center, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN

Zhuoer Xie, MD, MS1, Kristen McCullough, PharmD2, Terra L. Lasho, PhD3, Jenna A. Fernandez, PhD3*, Christy Finke, BS3*, Michelle Renee Amundson3*, Betsy Laplant, MS4*, Abhishek A. Mangaonkar, MBBS3, Naseema Gangat, MBBS3, Kaaren K. Reichard, MD5*, Michelle A Elliott, MD3, Thomas E. Witzig, MD3 and Mrinal M. M. Patnaik, MD, MBBS3

1Division of Hematology, Mayo Clinic, Lutz, FL
2Division of Pharmacology, Mayo Clinic, Rochester, MN
3Division of Hematology, Mayo Clinic, Rochester, MN
4Division of Clinical Trials & Biostatistics, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
5Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN

*signifies non-member of ASH